Nurse Practitioner in W Burlington, IA Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Mrs. Kelley Michelle Dawley, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1225 S Gear Ave Ste 153, W Burlington, IA 52655 Phone: 319-754-4400 Fax: 319-754-4412 |
News Archive
IDIBELL researchers explain the regulator mechanisms of mitosis
Researchers at the Cell Cycle Research Group of the Bellvitge Institute of Biomedical Research (IDIBELL) led by Ethel Queralt have reported in the journal PLoS Genetics an article which delve into the regulator mechanisms of mitosis, a key stage of the cell-cycle for the correct transmision of genetic information from parents to sons.
Dongkook Pharmaceutical to launch Probi Mage dietary supplement in South Korea
Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd., based in Seoul, South Korea for the distribution of Probi´s gut health product, Probi Mage®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014.
Obesity becoming serious problem, comparable to cigarette smoking
Dr. Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University has published a report in the current issue of the American Journal of Medicine that obesity is becoming as big a hazard worldwide, comparable to cigarette smoking.
NexMed files IND with FDA for Phase II trial of PrevOnco for HCC
NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.
Aromatase inhibitors most effective in preventing breast cancer from coming back
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
› Verified 4 days ago